Embolization with transient materials
OwnerAmarpreet S. Sawhney, Timothy S. Jarrett +1inventors
InventorsAmarpreet S. Sawhney, Timothy S. Jarrett, Hans Claesson
Life of this patent
Estimating the term…
Abstract
Use of embolic material that is biodegradable provides for embolizing a hypervascular vessel formed in response to chronic inflammation in a musculoskeletal vasculature or a vessel related to production of ghrelin. The embolic material is biodegradable within a predetermined period of time. Medical systems are configured for delivery of embolic material for embolizing the hypervascular vessel or the vessel related to production of ghrelin.
Claims21
A method of embolizing a hypervascular vessel formed in response to chronic inflammation in a musculoskeletal vasculature, the method comprising
- advancing a catheter through a vasculature to a parent artery;
- and
- releasing an embolic material from a distal end of the catheter into a hypervascular vessel, with the embolic material blocking blood flow in the hypervascular vessel;
- wherein the embolic material is biodegradable within a predetermined period of time.
A method for embolizing a vessel related to production of ghrelin, the method comprising;
- advancing a catheter through a vasculature to a parent artery;
- and
- releasing an embolic material from a distal end of the catheter into a vessel related to production of ghrelin, with the embolic material blocking blood flow in the vessel.
A medical system for treatment of a hypervascular vessel formed in response to chronic inflammation in a musculoskeletal vasculature or of a vessel related to production of ghrelin, the medical system comprising:
- a catheter suitable for delivery through a patient's vasculature to reach the hypervascular vessel or the vessel related to production of ghrelin;
- and
- a delivery component comprising a reservoir of embolic material and a delivery device configured to deliver the embolic material through the catheter.
Dependencies are inferred from the claim text.